Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 May 16;4(5):101039.
doi: 10.1016/j.xcrm.2023.101039.

From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer

Affiliations
Comment

From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer

Y David Seo et al. Cell Rep Med. .

Abstract

Tintelnot et al.1 identified enrichment of indole-3-acetic acid (3-IAA), a tryptophan metabolite produced by gut microbiota, as a predictor of chemotherapy response in pancreatic adenocarcinoma. Recapitulated in mouse models, 3-IAA represents a novel potential therapeutic approach for chemotherapy sensitization.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.A.W. is an inventor on a US patent application (PCT/US17/53.717); reports compensation for speaker’s bureau and honoraria from Imedex, Dava Oncology, Omniprex, Illumina, Gilead, PeerView, MedImmune, and Bristol-Myers Squibb; serves as a consultant/advisory board member for Roche/Genentech, Novartis, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Merck, Biothera Pharmaceuticals, and Micronoma. J.A.W. holds stock options from Micronoma.

Figures

Figure 1
Figure 1
Proposed mechanism of action of gut microbiota-mediated 3-IAA chemosensitization Indole-3-acetic acid (3-IAA) is a metabolite of tryptophan broken down by gut microbiota, and higher serum 3-IAA levels were found in pancreatic cancer patients who responded to chemotherapy. The gut microbiome of responders was enhanced in 3-IAA producers (including Bacteroides). Through multiple loss-of- and gain-of-function pre-clinical experiments, the authors demonstrate neutrophil-mediated accumulation of reactive oxygen species, which led to improved response to chemotherapy.

Comment on

  • Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.
    Tintelnot J, Xu Y, Lesker TR, Schönlein M, Konczalla L, Giannou AD, Pelczar P, Kylies D, Puelles VG, Bielecka AA, Peschka M, Cortesi F, Riecken K, Jung M, Amend L, Bröring TS, Trajkovic-Arsic M, Siveke JT, Renné T, Zhang D, Boeck S, Strowig T, Uzunoglu FG, Güngör C, Stein A, Izbicki JR, Bokemeyer C, Sinn M, Kimmelman AC, Huber S, Gagliani N. Tintelnot J, et al. Nature. 2023 Mar;615(7950):168-174. doi: 10.1038/s41586-023-05728-y. Epub 2023 Feb 22. Nature. 2023. PMID: 36813961 Free PMC article.

References

    1. Tintelnot J., Xu Y., Lesker T.R., Schonlein M., Konczalla L., Giannou A.D., Pelczar P., Kylies D., Puelles V.G., Bielecka A.A., et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature. 2023;615:168–174. - PMC - PubMed
    1. Conroy T., Hammel P., Hebbar M., Ben Abdelghani M., Wei A.C., Raoul J.L., Chone L., Francois E., Artru P., Biagi J.J., et al. FOLFIRINOX or gemcitabine as Adjuvant therapy for pancreatic cancer. N. Engl. J. Med. 2018;379:2395–2406. - PubMed
    1. Sturm N., Ettrich T.J., Perkhofer L. The impact of Biomarkers in pancreatic Ductal adenocarcinoma on Diagnosis, Surveillance and therapy. Cancers. 2022;14:217. - PMC - PubMed
    1. Gopalakrishnan V., Helmink B.A., Spencer C.N., Reuben A., Wargo J.A. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell. 2018;33:570–580. - PMC - PubMed
    1. Spencer C.N., McQuade J.L., Gopalakrishnan V., McCulloch J.A., Vetizou M., Cogdill A.P., Khan M.A.W., Zhang X., White M.G., Peterson C.B., et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021;374:1632–1640. - PMC - PubMed